Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

258
The pathophysiology of pneumonia involves the following steps:
258
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

221
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
221
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

202
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
202
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alpha-1 Antitrypsin Replacement Improves Walking Capacity in Subjects With Severe Deficiency.

Respiratory care·2026
Same author

Sarcopenia and Comorbidity Burden Independently Predict Cough Impairment in Hospitalized Patients: A Cross-Sectional Study.

Journal of clinical medicine·2026
Same author

Oxidative Stress Biomarkers in Silicosis: A Systematic Review.

Diseases (Basel, Switzerland)·2026
Same author

Multi-omics to study chronic respiratory diseases and viral infections.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

GDF11: A promising new drug target for pulmonary fibrosis?

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

A rare case of sudden blindness following mepolizumab withdrawal in EGPA.

Current medical research and opinion·2025

相关实验视频

Updated: Jun 25, 2025

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3
07:35

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Published on: April 13, 2009

8.2K

在Poxviridae肺炎肺炎.

Francesco Nucera1, Letterio Bonina2, Antonino Cipolla3

  • 1Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy.

Advances in experimental medicine and biology
|May 27, 2024
PubMed
概括

包括天花和MPXV在内的Poxviridae病毒可以引起严重的肺炎. 目前的治疗重点是支持性护理,抗病毒药物如tecovirimab,以及FDA批准的预防疫苗.

关键词:
牛是一种牛病.MPXVMPXV MPXVVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPX小天花是一种天花.疫苗和疫苗是不同的.这种疾病叫做Variola Variola.

更多相关视频

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2
10:55

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Published on: April 10, 2009

8.0K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.3K

相关实验视频

Last Updated: Jun 25, 2025

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3
07:35

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Published on: April 13, 2009

8.2K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2
10:55

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Published on: April 10, 2009

8.0K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.3K

科学领域:

  • 病毒学 病毒学
  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学

背景情况:

  • 病毒类病毒可以在人类中引起严重的肺炎,在历史上与天花病毒 (天花) 有关,目前与病毒 (MPXV) 有关.
  • 肺炎带来潜在的并发症,如急性呼吸窘迫综合征 (ARDS) 和死亡,特别是在免疫功能低下的人群中.
  • 病理生理学涉及直接的病毒损伤和超炎性反应 (细胞因子风暴),病毒免疫逃避机制也被描述.

研究的目的:

  • 审查Poxviridae相关肺炎的临床表现,病理生理学和管理.
  • 突出Poxviridae肺炎作为潜在的生物威胁和公共卫生问题的重要性.
  • 总结当前和新兴的治疗和预防策略.

主要方法:

  • 关于Poxviridae感染和肺炎的文献综述.
  • 分析临床病例报告和动物模型研究.
  • 美国食品和药物管理局批准的治疗方法和疫苗的摘要.

主要成果:

  • 脊髓灰质炎的肺炎可能是严重的,脊髓灰质炎病毒在历史上造成了显著的死亡率,MPXV构成了当前的风险.
  • 动物模型表明直接的上皮损伤和高炎症有助于疾病的严重程度.
  • 有抗病毒药物 (tecovirimat,cidofovir,brincidofovir) 和疫苗 (JYNNEOS,ACAM2000) 可用于治疗和预防.

结论:

  • 肺炎需要仔细的支持性护理和有针对性的抗病毒疗法.
  • 疫苗接种仍然是预防严重疾病和管理疫情的关键工具.
  • 对病理生理学和治疗的持续研究对于应对这种病毒威胁至关重要.